fidaxomicin (Dificid)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Pregnancy category: B

Safety in lactation: ?

Dosage

  • 200 PO BID with or without food for 10 days

Tablets: 200 mg

Oral Suspension

Pharmacokinetics

Adverse effects

Drug interactions

Mechanism of action

More general terms

References

  1. FDA NEWS RELEASE: May 27, 2011 FDA approves treatment for Clostridium difficile infection http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm257024.htm
  2. Prescriber's Letter 18(7): 2011 New Drug: Fidaxomicin (Dificid) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=270710&pb=PRL (subscription needed) http://www.prescribersletter.com
  3. 3.0 3.1 Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019
  4. 4.0 4.1 NEJM Knowledge+ Gastroenterology
  5. HIGHLIGHTS OF PRESCRIBING INFORMATION DIFICID (fidaxomicin) tablet, oral suspension https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213138lbl.pdf

Database